Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Encompass HealthMEX:EHC 76 5-Year Yield-on-Cost % is 0.09 as of Jul. 16, 2026, which is 91% below its 10-year median of 0.99. GuruFocus rates MEX:EHC with a GF Score™ of 76/100 and a GF Value™ of MXN1,970.57 (Fairly Valued). The stock has 1 warning sign investors should review. Among 280 Healthcare Providers & Services companies, Encompass Health ranks worse than 91.43% on this metric.
Encompass Health's yield on cost for the quarter that ended in Mar. 2026 was 0.09.
The historical rank and industry rank for Encompass Health's 5-Year Yield-on-Cost % or its related term are showing as below:
MEX:EHC'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.09 Med: 0.99 Max: 1.63
Current: 0.09
During the past 13 years, Encompass Health's highest Yield on Cost was 1.63. The lowest was 0.09. And the median was 0.99.
MEX:EHC's 5-Year Yield-on-Cost % is ranked worse than 91.43% of 280
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs MEX:EHC: 0.09
Encompass Health (MEX:EHC) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Encompass Health 5-Year Yield-on-Cost % Related Terms
MEX:EHC vs ENSG, UHS, PACS: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Encompass Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encompass Health 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Encompass Health's 5-Year Yield-on-Cost % falls into.
Encompass Health 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Encompass Health (MEX:EHC) has a 5-Year Yield-on-Cost % of 0.09 as of Jul. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Encompass Health and its competitors. This is 91% below median its historical median of 0.99. Over the past decade, Encompass Health's 5-Year Yield-on-Cost % has ranged from 0.09 to 1.63. According to the industry distribution chart, Encompass Health ranks #256 out of 280 companies in the Healthcare Providers & Services industry, placing it in the top 91.4%.
Is Encompass Health's 5-Year Yield-on-Cost % too high?
Encompass Health's current 5-Year Yield-on-Cost % of 0.09 is 91% below median its 10-year median of 0.99. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 1.63. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Encompass Health's value of 0.09 is 96.9% below this industry median. Based on the distribution chart, Encompass Health ranks #256 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Encompass Health has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's 5-Year Yield-on-Cost % compare to ENSG and UHS?
According to the Healthcare Providers & Services industry distribution chart, Encompass Health ranks #256 out of 280 companies for 5-Year Yield-on-Cost %. This places Encompass Health in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. Encompass Health's value of 0.09 is 96.9% below this benchmark. Historically, Encompass Health's own 5-Year Yield-on-Cost % has ranged from 0.09 to 1.63 over the past decade. While the company's 10-year median is 0.99 vs. the industry median of 2.90, Encompass Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encompass Health's current 5-Year Yield-on-Cost % of 0.09 is 96.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Encompass Health and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encompass Health's current 5-Year Yield-on-Cost % is 0.09, which is 91% below median its own 10-year median of 0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Based on GuruFocus' analysis, Encompass Health (MEX:EHC) is currently considered Fairly Valued. The stock's GF Value™ is MXN1,970.57, compared to a current price of MXN1,930.00 — trading 2.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.09, which is 91% below median its 10-year median of 0.99 and 96.9% below the Healthcare Providers & Services industry median of 2.90. Encompass Health's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current 5-Year Yield-on-Cost % is 0.09 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Encompass Health (MEX:EHC) Overvalued in 2026?
Based on GuruFocus' analysis, Encompass Health stock appears to be undervalued.
The current stock price of MXN1,930.00 is trading 2.1% below its estimated GF Value™ of MXN1,970.57.
GuruFocus considers Encompass Health to be Fairly Valued.
Key valuation signals for MEX:EHC:
5-Year Yield-on-Cost %: 0.09 (91% below median its 10-year median of 0.99)
GF Value™: MXN1,970.57 vs. price of MXN1,930.00 (2.1% below fair value)
Industry Position: 96.9% below the Healthcare Providers & Services median (#256 of 280)
No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
76GF Score
Get the complete analysis for MEX:EHC
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EHC has been successfully added to your 
